NIH Earmarks $28M to Fund Study into Measurements of Autism Markers
The study is part of the Biomarkers Consortium, and will include the collection of DNA samples for future genomics research into ASD.
Caprion Launches MRM-MS-based CNS Assay as Part of Push into Protein Discovery Panel Business
NEW YORK (GenomeWeb) – Proteomics firm Caprion this week launched its CNS ProteoCarta panel for the study of central nervous system diseases.
GMU Phosphoproteomic Studies Offer Potential Clinical Insights on Breast, Colorectal Cancers
Teams led by researchers at George Mason University have published a pair of studies exploring protein signaling in breast and colon cancer that could offer new insights into treatments for the diseases.
Technology developed by Lance Liotta and Emanuel Petricoin will be used to find and identify biomarkers for evaluating new investigational therapies for the neoadjuvant-drug study.
NIH Foundation, Biomarkers Consortium Team on Cancer Trials
The I-SPY effort will conduct pharmacogenomics-focused clinical trials for breast cancer drugs using Agendia's tests.